Nanorobotics: Revolutionizing Cancer Treatment And Early Diagnosis With Precision Technology

Abstract

Background: The techniques utilized so far depend mostly on chemical treatments like chemotherapy, though very effective, leave important side effects and a limited degree of precision. New developments in nanorobotics are bringing much more hope for the most accurate, minimally invasive treatment of cancer.
Objectives: The primary purpose of this study is to find out the potential of nanorobotics in changing the method of treatment and diagnosis at an early stage for cancer patients. More specifically, a research seeks to determine whether nanorobots can enhance the degrees of tumor targeting, side effects, survival rates, and even a personalized form of chemotherapy.
Methodology: The study uses a mixed-methods approach: a systematic review of existing literature combined with simulation-based analysis. A systematic review combines findings from various studies about the use of nanotechnology in cancer careThis data is tested using statistical software such as descriptive analysis and t-tests.
Results: The simulation study revealed that nanorobots decreased the mean size of tumors by 65.2% compared to chemotherapy, which led to a mean decrease of 40.5% in tumor size. The nanorobotics was said also to be effective for drug delivery with high accuracy percentages to the extent of 92.7% compared to 58.3% and with faster detection of a tumor than chemotherapy at 6.1 weeks against 12.3 weeks while the side effects that occurred were significantly lower since the severity score was 2.1 against 6.7 in chemotherapy. The survival rate of patients who were on nanorobot treatment within 12 months was 78% while that of the patients given chemotherapy was 54%.
Conclusion: Precise targeting with minimal side effects, it is more effective and increases survival rates. Thus, nanorobotics will play a vital role in personalized cancer treatment and even be the bedrock for it; more patient-friendly alternatives to already existing therapies.
Specific Contribution: The current study provides a comprehensive review of the potential of nanorobotics in oncology. It demonstrates new insights into practical benefits through integration of a systematic review and simulation data, thus opening up lines of future research and prospective clinical trials to validate such findings and implement nanorobotics as routine treatment methods for cancer.